| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-04 | 2025-02-25 | 2024-02-26 | 2023-03-06 | 2022-03-07 | 2020-12-31 | 2019-12-31 |
| Revenue | 133.7 | 131.2 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 14.11 | 5.28 | 0.383 | 0.531 | 0.199 | 0.155 | 0 |
| Gross Profit | 119.6 | 125.9 | -0.383 | -0.531 | -0.199 | -0.155 | 0 |
| Operating Expenses | 285.2 | 343.2 | 205.7 | 146.4 | 72.54 | 13.63 | 14.9 |
| Research & Development | 169 | 227.7 | 130.5 | 85.62 | 43.58 | 9.1 | 13.9 |
| Selling, General and Administrative | 116.2 | 115.5 | 75.16 | 60.76 | 28.96 | 4.53 | 1.01 |
| Other Operating Expenses | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -165.6 | -217.3 | -206.1 | -146.9 | -72.74 | -13.78 | -14.9 |
| Net Non-Operating Interest | 20.38 | 19.7 | 17.19 | 4.75 | 0.004 | -0.03 | -2.08 |
| Interest Income | 20.38 | 19.7 | 17.19 | 4.75 | 0.004 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.03 | 2.08 |
| Equity & Other Income/(Expense) | -0.036 | 109.2 | -0.04 | -0.018 | -0.015 | -30.03 | -0.002 |
| Income Before Tax | -145.3 | -88.35 | -188.9 | -142.2 | -72.75 | -43.84 | -16.98 |
| Income Tax Expense | 6.47 | 7.14 | 0 | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | -2.11 | -3.34 | -4.35 |
| Net Income | -151.8 | -95.5 | -188.9 | -142.2 | -70.64 | -40.51 | -12.63 |
| Depreciation and Amortization | 3.56 | 2.03 | 0.383 | 0.531 | 0.199 | 0.155 | 14.9 |
| EBITDA | -162.1 | -215.2 | -205.7 | -146.4 | -72.54 | -13.63 | 0 |
| Earnings Per Share (EPS) | -1.53 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Diluted Earnings Per Share | -1.53 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Weighted Average Shares Outstanding | 103.4 | 93.62 | 79.77 | 65.47 | 61.95 | 61.93 | 61.93 |
| Diluted Weighted Average Shares Outstanding | 103.4 | 93.62 | 79.77 | 65.47 | 61.95 | 61.93 | 61.93 |
